OptiBiotix Health (LON:OPTI) Stock Price Down 6.9% – Should You Sell?

OptiBiotix Health Plc (LON:OPTI)’s share price fell 6.9% on Monday . The company traded as low as GBX 15.66 ($0.20) and last traded at GBX 15.66 ($0.20). 378,448 shares traded hands during trading, an increase of 140% from the average session volume of 157,785 shares. The stock had previously closed at GBX 16.82 ($0.21).

OptiBiotix Health Stock Down 6.9 %

The firm has a market cap of £15.34 million, a price-to-earnings ratio of -522.00 and a beta of 1.71. The company has a quick ratio of 7.89, a current ratio of 6.18 and a debt-to-equity ratio of 4.51. The firm has a fifty day moving average price of GBX 17.15 and a 200-day moving average price of GBX 18.37.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.